ATLANTA, GA – – (Businesswire – August 1, 2017) – – Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased IntelliPharmaCeutics International, Inc. (“IntelliPharmaCeutics” or the “Company”) (NASDAQ: IPCI) common stock between January 14, 2016 and July 26, 2017. The case alleges that the Company and certain of its executive officers made false and misleading statements during that time. Specifically, the Complaint alleges the Company failed to submit sufficient evidence to the FDA to support its New Drug Application for its main product candidate, Rexista. On July 27, 2017, the Company’s stock price declined significantly following the FDA’s announcement that “the safety information collected in the pharmacokinetic studies [for Rexista] was of limited value.” If you purchased IntelliPharmaCeutics common stock between January 14, 2016 and July 26, 2017 and suffered losses on that investment, you are encouraged to visit the firm’s website at www.holzerlaw.com to receive additional information about your legal rights. You can also contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Alexandria P. Rankin, Esq. at arankin@holzerlaw.com, or call the firm by toll-free telephone at (888) 508-6832 for more information. The case is pending in the United States District Court for the Southern District of New York and the deadline to move for appointment as lead plaintiff is September 29, 2017.

Provide Your Information To Take Action

  • Plaintiff Certifies That:
    1. Plaintiff has reviewed the complaint and authorized its filing.
    2. Plaintiff did not acquire the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this private action or any other litigation under the federal securities laws.
    3. Plaintiff is willing to serve as a representative party on behalf of a class, including providing testimony at deposition and trial, if necessary.
    4. Plaintiff represents and warrants that he/she/it is fully authorized to enter into and execute this certification.
    5. Plaintiff will not accept any payment for serving as a representative party on behalf of a class beyond the Plaintiff's pro rata share of any recovery, except such reasonable costs and expenses (including lost wages) directly relating to the representation of the class as ordered or approved by the court.
    6. Plaintiff has made no transaction(s) during the Class Period in the debt or equity securities that are the subject of this action except those set forth below:
  • Date PurchasedNumber of Shares AcquiredAcquisition Price Per Share 
    Add a new row
  • Date SoldNumber of Shares SoldSelling Price Per Share 
    Add a new row
  • Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.